|
1. |
Environmental Aspects of Arsenic Toxicity |
|
Critical Reviews in Clinical Laboratory Sciences,
Volume 33,
Issue 6,
1996,
Page 457-493
PetersGregory R.,
McCurdyRoss F.,
HindmarshJ. Thomas,
Preview
|
PDF (1985KB)
|
|
摘要:
AbstractThe toxicity of arsenic and its long history of use in human culture has resulted in widespread concern about the natural and anthropogenic levels of arsenic in our environment. In this article, an overview of the current environmental status of arsenic is presented. A brief history of the usage of this element is followed by a discussion of the current applications. Both natural as well as anthropogenic sources of input are described and discussed in terms of their relative impact on the Earth's environment. Numerous control mechanisms for arsenic exist in the environment, and the major processes involved (physical, chemical, and biological) are highlighted. Natural cycling of this element through the various environmental compartments (air, water, soil, and biota) are described as well as some current methods for the removal of arsenic from natural and industrial waters. Finally, a brief overview of the most common methods for the analysis of arsenic in environmental samples is presented.
ISSN:1040-8363
DOI:10.3109/10408369609080055
出版商:Taylor&Francis
年代:1996
数据来源: Taylor
|
2. |
Lipoprotein(a) in Health and Disease |
|
Critical Reviews in Clinical Laboratory Sciences,
Volume 33,
Issue 6,
1996,
Page 495-543
KronenbergFlorian,
SteinmetzArmin,
KostnerGerhard M.,
DieplingerHans,
Preview
|
PDF (2807KB)
|
|
摘要:
AbstractLipoprotein(a) [Lp(a)] represents an LDL-like particle to which the Lp(a)-specific apolipoprotein(a) is linked via a disulfide bridge. It has gained considerable interest as a genetically determined risk factor for atherosclerotic vascular disease. Several studies have described a correlation between elevated Lp(a) plasma levels and coronary heart disease, stroke, and peripheral atherosclerosis. In healthy individuals, Lp(a) plasma concentrations are almost exclusively controlled by the apo(a) gene locus on chromosome 6q2.6-q2.7. More than 30 alleles at this highly polymorphic gene locus determine a size polymorphism of apo(a). There exists an inverse correlation between the size (molecular weight) of apo(a) isoforms and Lp(a) plasma concentrations.The standardization of Lp(a) quantification is still an unresolved task due to the large panicle size of Lp(a), the presence of two different apoproteins [apoB and apo(a)], and the large size polymorphism of apo(a) and its homology with plasminogen. A working group sponsored by the IFCC is currently establishing a stable reference standard for Lp(a) as well as a reference method for quantitative analysis.Aside from genetic reasons, abnormal Lp(a) plasma concentrations are observed as secondary to various diseases. Lp(a) plasma levels are elevated over controls in patients with nephrotic syndrome and patients with end-stage renal disease. Following renal transplantation, Lp(a) concentrations decrease to values observed in controls matched for apo(a) type.Controversial data on Lp(a) in diabetes mellitus result mainly from insufficient sample sizes of numerous studies. Large studies and those including apo(a) phenotype analysis came to the conclusion that Lp(a) levels are not or only moderately elevated in insulin-dependent patients. In noninsulin-dependent diabetics, Lp(a) is not elevated.Conflicting data also exist from studies in patients with familial hypercholesterolemia. Several case-control studies reported elevated Lp(a) levels in those patients, suggesting a role of the LDL-receptor pathway for degradation of Lp(a). However, recent turnover studies rejected that concept. Moreover, family studies also revealed data arguing against an influence of the LDL receptor for Lp(a) concentrations.Several rare diseases or disorders, such as LCAT- and LPL-deficiency as well as liver diseases, are associated with low plasma levels or lack of Lp(a).
ISSN:1040-8363
DOI:10.3109/10408369609080056
出版商:Taylor&Francis
年代:1996
数据来源: Taylor
|
|